A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit

Purpose Cystic fibrosis (CF) is an inherited life-shortening disease involving a significant treatment burden. Few interventions have been proven effective in improving adherence, and of these fewer have been adopted for implementation. Patient participation in research is increasingly desired in developing relevant health care services. A participatory approach was implemented in an adult CF center to co-design an adherence-enhancing intervention toolkit. We aimed to report on the participatory process and the results regarding the co-designed intervention. Patients and Methods Two focus group sessions and four working sessions were conducted at 4-week intervals with three healthcare professionals (HCP; physician, nurse, physiotherapist), eight patients, and two researchers (sociologist, public health pharmacist). The two initial focus group sessions were dedicated to the collection of narratives about CF treatment experiences to identify drivers of adherence. The next four working sessions were dedicated to the reflection on solutions that could alleviate the difficulties identified and be used in current clinical practice. The researchers observed during all sessions the interactions between participants, group dynamics, and process of implementation of the collective reflection. Results The process facilitated an active participation of patients and HCP, who contributed equally to the intervention development. The co-design adherence-enhancing intervention toolkit consisted in a self-questionnaire to be completed by patients before the medical consultation and used as a communication support during the consultation, plus a toolkit of solutions to be proposed by the HCP for each barrier identified by patients, and to be followed up during the next consultation. Conclusion This study demonstrated that a participatory approach involving CF patients and HCP lead to the development of an adherence-enhancing intervention toolkit, using a 6-session format; the benefits of the co-designed intervention on the medication adherence have yet to be tested in a multicenter, open-label study in 3 centers in France.

[1]  R. Fischer,et al.  A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF , 2021, BMC Pulmonary Medicine.

[2]  E. Naureckas,et al.  Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience , 2020, Journal of participatory medicine.

[3]  Alexander K. Saeri,et al.  Research co-design in health: a rapid overview of reviews , 2020, Health Research Policy and Systems.

[4]  J. Ainsworth,et al.  Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub , 2020, Pilot and Feasibility Studies.

[5]  K. Riekert,et al.  Clustered randomized controlled trial of a clinic-based problem-solving intervention to improve adherence in adolescents with cystic fibrosis. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  Samuel S Allemann,et al.  Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data , 2019, Patient preference and adherence.

[7]  S. Donaldson,et al.  Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  G. Bellis,et al.  French Cystic Fibrosis Registry. Annual data report 2017 , 2019 .

[9]  J. Ainsworth,et al.  Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study , 2019, BMC Pulmonary Medicine.

[10]  N. Kaciroti,et al.  Impact of home spirometry on medication adherence among adolescents with cystic fibrosis , 2018, Pediatric pulmonology.

[11]  P. Lombrail,et al.  Lessons from patient and parent involvement (P&PI) in a quality improvement program in cystic fibrosis care in France , 2018, Orphanet Journal of Rare Diseases.

[12]  E. Hatziagorou,et al.  Telephone monitoring and home visits significantly improved the quality of life, treatment adherence and lung function in children with cystic fibrosis , 2017, Acta paediatrica.

[13]  K. Boisen,et al.  Coach to cope: feasibility of a life coaching program for young adults with cystic fibrosis , 2017, Patient preference and adherence.

[14]  E. Nash,et al.  The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers , 2017, Thorax.

[15]  D. G. Altman,et al.  GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research , 2017, Research Involvement and Engagement.

[16]  H. Elphick,et al.  Investigating the feasibility of text message reminders to improve adherence to nebulized medication in children and adolescents with cystic fibrosis , 2017, Patient preference and adherence.

[17]  L. Bentur,et al.  The use of telehealth (text messaging and video communications) in patients with cystic fibrosis: A pilot study , 2017, Journal of telemedicine and telecare.

[18]  C. Duncan,et al.  A Quality Improvement Initiative to Improve Patient Adherence to Vitamin Supplementation in Cystic Fibrosis , 2017, Journal of pediatric gastroenterology and nutrition.

[19]  J. Mainz,et al.  Adherence to therapies in cystic fibrosis: a targeted literature review , 2017, Expert review of respiratory medicine.

[20]  Z. Hoo,et al.  Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherence , 2015, Patient preference and adherence.

[21]  B. Fullen,et al.  Adherence of Subjects With Cystic Fibrosis to Their Home Program: A Systematic Review , 2014, Respiratory Care.

[22]  Colin Tysall,et al.  A Systematic Review of the Impact of Patient and Public Involvement on Service Users, Researchers and Communities , 2014, The Patient - Patient-Centered Outcomes Research.

[23]  K. Riekert,et al.  Pulmonary medication adherence and health-care use in cystic fibrosis. , 2014, Chest.

[24]  Z. Hoo,et al.  Moving cystic fibrosis care from rescue to prevention by embedding adherence measurement in routine care. , 2014, Paediatric respiratory reviews.

[25]  Paul B Batalden,et al.  The interdependent roles of patients, families and professionals in cystic fibrosis: a system for the coproduction of healthcare and its improvement , 2014, BMJ quality & safety.

[26]  J. Sloan,et al.  Patient engagement in research: a systematic review , 2014, BMC Health Services Research.

[27]  K. Riekert,et al.  The impact of medication adherence on lung health outcomes in cystic fibrosis , 2013, Current opinion in pulmonary medicine.

[28]  G. Sawicki,et al.  Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[29]  F. Godlee,et al.  Let the patient revolution begin , 2013, BMJ.

[30]  M. Broder,et al.  Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis , 2013, Journal of medical economics.

[31]  J. Sweeney,et al.  Patient and family engagement: a framework for understanding the elements and developing interventions and policies. , 2013, Health affairs.

[32]  S. Madge,et al.  Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis. , 2011, Respiratory medicine.

[33]  K. Riekert,et al.  Perceptions of barriers and facilitators: self-management decisions by older adolescents and adults with CF. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[34]  Olivier Las Vergnas,et al.  Construction et reconnaissance des savoirs expérientiels des patients , 2010 .

[35]  G. Latchford,et al.  Motivational interviewing for adherence problems in cystic fibrosis , 2010, Pediatric pulmonology.

[36]  Lisa Saiman,et al.  Cell phone intervention to improve adherence: Cystic fibrosis care team, patient, and parent perspectives , 2010, Pediatric pulmonology.

[37]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[38]  G. Sawicki,et al.  High treatment burden in adults with cystic fibrosis: challenges to disease self-management. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[39]  R. Gagnayre,et al.  Le conducteur pédagogique : une aide pour mener des séances d’éducation thérapeutique , 2008 .

[40]  P. L. Le Souëf,et al.  Benefits of an education programme on the self-management of aerosol and airway clearance treatments for children with cystic fibrosis , 2006, Chronic respiratory disease.

[41]  Richard A. Krueger,et al.  Moderating Focus Groups , 1997 .

[42]  L. Wirth.  Clinical Sociology , 1931, American Journal of Sociology.

[43]  K. Riekert,et al.  Opportunities for cystic fibrosis care teams to support treatment adherence. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[44]  W. Lenney,et al.  Developing a handheld record for patients with cystic fibrosis , 2015 .

[45]  J. Rhéaume.  Community Development and Empowerment: A Clinical Sociology Perspective , 2014 .

[46]  P. Beirne,et al.  Self-management education for cystic fibrosis. , 2011, Cochrane Database of Systematic Reviews.

[47]  Paul Turner,et al.  Enhancing Self-Efficacy for Self-Management in People with Cystic Fibrosis , 2011, MIE.

[48]  V. D. Gaulejac.  On the Origins of Clinical Sociology in France: Some Milestones , 2008 .

[49]  J. Kitzinger.  The methodology of focus groups: the importance of interaction between research participants , 1994 .

[50]  P. Lazarsfeld,et al.  Section: Overview of the Field: Definitions and History , 1989 .